This HTML5 document contains 193 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
n14	http://linked.opendata.cz/resource/sukl/roa/
n2	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/
dcterms	http://purl.org/dc/terms/
n3	http://linked.opendata.cz/ontology/sukl/
n18	http://linked.opendata.cz/resource/sukl/specialization-restriction/
skos	http://www.w3.org/2004/02/skos/core#
n13	http://linked.opendata.cz/resource/sukl/indgroup/
n8	http://linked.opendata.cz/resource/sukl/packing/
n16	http://linked.opendata.cz/resource/sukl/company/
n11	http://linked.opendata.cz/resource/sukl/active-ingredient/
n5	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0117095/price-of-originator/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n10	http://linked.opendata.cz/resource/sukl/registration-state/
n9	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0117095/reimbursement/
n6	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0117095/
xsdh	http://www.w3.org/2001/XMLSchema#
n12	http://www.sukl.cz/modules/medication/
n15	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0117095/core-reimbursement/
n7	http://linked.opendata.cz/resource/sukl/df/
n20	http://linked.opendata.cz/resource/atc/
n4	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0117095/price/

Statements

Subject Item

n2:0117095

rdf:type

n3:MedicinalProductPackaging

dcterms:title

IRINOTECAN TEVA 20 MG/ML

skos:notation

0117095

n3:hasATCCode

n20:L01XX19

n3:hasActiveIngredient

n11:IRINOTECANI-HYDROCHLORIDUM-TRIHYDRICUM

n3:hasDefinedDailyDose

n6:ddd

n3:hasDosageForm

n7:CNC-SOL-INF

n3:hasPackagingSize

1X2ML I

n3:hasPacking

n8:VIA

n3:hasRegistrationHolder

n16:TPPCZ

n3:hasRegistrationState

n10:R

n3:hasRouteOfAdministration

n14:INF

n3:hasStrength

20MG/ML

n3:hasIndicationGroup

n13:44

n3:hasSpecializationRestriction

n18:ONK

n3:containsDefinedDailyDoses

0.0

n3:hasRegistrationCode

44/ 354/08-C

n3:hasTitleSupplement

INF CNC SOL 1X2ML/40MG

n3:containsUsualTherapeuticalDailyDoses

1.3874 1.7983

n3:hasBreakMarketingDate

2013-06-18+02:00 2011-02-14+01:00 2015-05-01+02:00

n3:hasCoreReimbursementSpecification

n15:2014-01-01 n15:2014-02-01 n15:2013-11-01 n15:2013-12-01 n15:2013-09-01 n15:2013-10-01 n15:2013-08-01 n15:2013-08-03 n15:2014-07-03 n15:2014-08-01 n15:2014-06-13 n15:2014-07-01 n15:2014-05-01 n15:2014-06-01 n15:2014-03-01 n15:2014-04-01 n15:2015-01-01 n15:2015-01-13 n15:2014-11-19 n15:2014-12-01 n15:2014-10-02 n15:2014-11-01 n15:2014-09-01 n15:2014-10-01 n15:2015-07-01 n15:2015-07-02 n15:2015-05-01 n15:2015-06-01 n15:2015-04-01 n15:2015-04-02 n15:2015-02-01 n15:2015-03-01 n15:2013-06-01 n15:2013-07-01 n15:2013-04-01 n15:2013-05-01 n15:2013-02-01 n15:2013-03-01 n15:2013-01-01 n15:2013-01-05

n3:hasIndicationRestriction

P

n3:hasPriceOfOriginatorSpecification

n5:2015-04-01 n5:2015-04-02 n5:2015-02-01 n5:2015-03-01 n5:2015-07-01 n5:2015-07-02 n5:2015-05-01 n5:2015-06-01 n5:2014-10-02 n5:2014-11-01 n5:2014-09-01 n5:2014-10-01 n5:2015-01-01 n5:2015-01-13 n5:2014-11-19 n5:2014-12-01 n5:2014-05-01 n5:2014-06-01 n5:2014-03-01 n5:2014-04-01 n5:2014-07-03 n5:2014-08-01 n5:2014-06-13 n5:2014-07-01 n5:2013-09-01 n5:2013-10-01 n5:2013-08-01 n5:2013-08-03 n5:2014-01-01 n5:2014-02-01 n5:2013-11-01 n5:2013-12-01 n5:2013-02-01 n5:2013-03-01 n5:2013-01-01 n5:2013-01-05 n5:2013-06-01 n5:2013-07-01 n5:2013-04-01 n5:2013-05-01

n3:hasPriceSpecification

n4:2013-02-01 n4:2013-03-01 n4:2015-05-01 n4:2015-06-01 n4:2015-07-01 n4:2015-07-02 n4:2015-02-01 n4:2015-03-01 n4:2015-04-01 n4:2015-04-02 n4:2014-11-19 n4:2014-12-01 n4:2015-01-01 n4:2015-01-13 n4:2014-09-01 n4:2014-10-01 n4:2014-10-02 n4:2014-11-01 n4:2014-06-13 n4:2014-07-01 n4:2014-07-03 n4:2014-08-01 n4:2014-03-01 n4:2014-04-01 n4:2014-05-01 n4:2014-06-01 n4:2013-11-01 n4:2013-12-01 n4:2014-01-01 n4:2014-02-01 n4:2013-08-01 n4:2013-08-03 n4:2013-09-01 n4:2013-10-01 n4:2013-04-01 n4:2013-05-01 n4:2013-06-01 n4:2013-07-01 n4:2013-01-01 n4:2013-01-05

n3:hasReimbursementSpecification

n9:2015-07-01 n9:2015-07-02 n9:2015-05-01 n9:2015-06-01 n9:2015-04-01 n9:2015-04-02 n9:2015-02-01 n9:2015-03-01 n9:2015-01-01 n9:2015-01-13 n9:2014-11-19 n9:2014-12-01 n9:2014-10-02 n9:2014-11-01 n9:2014-09-01 n9:2014-10-01 n9:2014-07-03 n9:2014-08-01 n9:2014-06-13 n9:2014-07-01 n9:2014-05-01 n9:2014-06-01 n9:2014-03-01 n9:2014-04-01 n9:2014-01-01 n9:2014-02-01 n9:2013-11-01 n9:2013-12-01 n9:2013-09-01 n9:2013-10-01 n9:2013-08-01 n9:2013-08-03 n9:2013-06-01 n9:2013-07-01 n9:2013-04-01 n9:2013-05-01 n9:2013-02-01 n9:2013-03-01 n9:2013-01-01 n9:2013-01-05

n3:hasResumedMarketingDate

2011-05-16+02:00 2014-07-22+02:00

n3:hasUsualTherapeuticalDailyDose

n6:utdd

n3:pilFile

http%3A%2F%2Fwww.sukl.cz%2Fmodules%2Fmedication%2Fdownload.php%3Ffile%3DPI50147.pdf%26type%3Dpil%26as%3Dirinotecan-teva-20-mg-ml-pil

n3:pilUri

n12:download.php?file=PI50147.pdf&type=pil&as=irinotecan-teva-20-mg-ml-pil

n3:spcFile

http%3A%2F%2Fwww.sukl.cz%2Fmodules%2Fmedication%2Fdownload.php%3Ffile%3DSPC50148.pdf%26type%3Dspc%26as%3Dirinotecan-teva-20-mg-ml-spc

n3:spcUri

n12:download.php?file=SPC50148.pdf&type=spc&as=irinotecan-teva-20-mg-ml-spc

n3:textOnTheWrapFile

http%3A%2F%2Fwww.sukl.cz%2Fmodules%2Fmedication%2Fdownload.php%3Ffile%3DOBAL50149.pdf%26type%3Dobal%26as%3Dirinotecan-teva-20-mg-ml-obal

n3:textOnTheWrapUri

n12:download.php?file=OBAL50149.pdf&type=obal&as=irinotecan-teva-20-mg-ml-obal